Drug profile · INN
gallium ga-68 edotreotide
GALLIUM GA 68 EDOTREOTIDE
gallium ga-68 edotreotide (GALLIUM GA 68 EDOTREOTIDE) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — gallium ga-68 edotreotide
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
gallium ga-68 edotreotide (GALLIUM GA 68 EDOTREOTIDE) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is gallium ga-68 edotreotide?
gallium ga-68 edotreotide (GALLIUM GA 68 EDOTREOTIDE) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gallium ga-68 edotreotide?
GALLIUM GA 68 EDOTREOTIDE is a marketed brand name for gallium ga-68 edotreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gallium ga-68 edotreotide?
gallium ga-68 edotreotide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.